Barbara Muoio

Bellinzona, TI, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.

Journal: ESMO open

Published: October 28, 2025

Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis.

Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis.

Journal: Cancers

Published: May 27, 2025

Sex-Related Differences in Glioblastoma: A Single-Center Retrospective Cohort Study.

Sex-Related Differences in Glioblastoma: A Single-Center Retrospective Cohort Study.

Journal: Biomedicines

Published: May 18, 2025

ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapy.

ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 16, 2025

The Prevalence and Significance of Incidental Positron Emission Tomography Findings in the Brain Using Radiotracers Other than [18F]FDG: A Systematic Review and Meta-Analysis.

The Prevalence and Significance of Incidental Positron Emission Tomography Findings in the Brain Using Radiotracers Other than [18F]FDG: A Systematic Review and Meta-Analysis.

Journal: Diagnostics (Basel, Switzerland)

Published: April 15, 2025

Gastric Adenocarcinoma Incidentally Detected by PET/CT with PSMA Ligands.

Gastric Adenocarcinoma Incidentally Detected by PET/CT with PSMA Ligands.

Journal: Diagnostics (Basel, Switzerland)

Published: December 17, 2024

"Rosary Sign" at Somatostatin Receptor PET in a Case of Recurrent Meningioma.

"Rosary Sign" at Somatostatin Receptor PET in a Case of Recurrent Meningioma.

Journal: Diagnostics (Basel, Switzerland)

Published: October 08, 2024

The Diagnostic Performance of 2-[18F]FDG PET/CT in Identifying Richter Transformation in Chronic Lymphocytic Leukemia: An Updated Systematic Review and Bivariate Meta-Analysis.

The Diagnostic Performance of 2-[18F]FDG PET/CT in Identifying Richter Transformation in Chronic Lymphocytic Leukemia: An Updated Systematic Review and Bivariate Meta-Analysis.

Journal: Cancers

Published: April 06, 2024

Diagnostic yield of FAP-guided positron emission tomography in thyroid cancer: a systematic review.

Diagnostic yield of FAP-guided positron emission tomography in thyroid cancer: a systematic review.

Journal: Frontiers in medicine

Published: February 04, 2024

Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis.

Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis.

Journal: Diagnostics (Basel, Switzerland)

Published: November 10, 2023

Diagnostic Accuracy of [68Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission Tomography: A Systematic Review and a Meta-Analysis.

Diagnostic Accuracy of [68Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission Tomography: A Systematic Review and a Meta-Analysis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 06, 2023

Neuro-Oncology and Positron Emission Tomography: "Just Can't Get Enough".

Neuro-Oncology and Positron Emission Tomography: "Just Can't Get Enough".

Journal: Cancers

Published: August 28, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026